درباره این اپیزود
This episode features authors of the KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis. Experts Dr. Gabriel Contreras and Dr. Sayna Norouzi joins host, Dr. Osama El Shamy to explore key guideline updates and how the recommendations can be applied in clinical practice. They discuss current approaches to diagnosis, newer therapies, treatment strategies based on disease class, and care for patients with a membranous component. The conversation also examines long-term complications, thrombotic microangiopathy, and practical challenges clinicians may encounter when implementing the updated recommendations.
Please click here to access the commentary.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Kidney Commute را جستجو کن.
قسمت های دیگر در این پادکست
In this episode of Kidney Commute: Pitstop, we explore key insights from the KDIGO Commentary on the 2025 KDOQI Clinical Practice Guideline for autosomal dominant polycystic kidney disease (ADPKD). Host Anna Gaddy is joined by Dr. Neera Dahl and Dr. Terry Watnick to discuss how the updated recommen…
Anemia in chronic kidney disease remains common, complex, and rapidly evolving. In this episode, experts discuss key updates from the 2026 KDIGO Clinical Practice Guidelines and AJKD commentary, including a stronger focus on identifying and treating iron deficiency and refining treatment strategies…
Kidney care rarely takes center stage in Congress, but a recent hearing is bringing renewed attention to prevention, innovation, and patient access. In this episode, host Raphy Rosen is joined by Dr. Suzanne Watnick, who testified as a witness at the March 18 Ways and Means Health Subcommittee hear…
IgA nephropathy and IgA vasculitis remain complex and evolving areas in nephrology care. In this episode, experts discuss key insights from the KDIGO guidelines and KDOQI commentary published in AJKD, focusing on updated approaches to risk stratification, disease progression, and treatment decision…
Phosphate additives are commonly used in processed and convenience foods, yet many patients and healthcare professionals remain unaware of how significantly they contribute to phosphorus burden in chronic kidney disease (CKD). Elevated phosphorus levels can negatively impact bone, cardiovascular, a…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به kidneycommute است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
